A rigorous evaluation of optimal peptide targets for MS-based clinical diagnostics of Coronavirus Disease 2019 (COVID-19).

Rajczewski, Andrew T; Mehta, Subina; Nguyen, Dinh Duy An; Grüning, Björn A; Johnson, James E; McGowan, Thomas; Griffin, Timothy J; Jagtap, Pratik D

Rajczewski, Andrew T; Mehta, Subina; Nguyen, Dinh Duy An; Grüning, Björn A; Johnson, James E; McGowan, Thomas; Griffin, Timothy J; Jagtap, Pratik D.

Afiliación

Rajczewski AT; Department of Biochemistry, Molecular Biology and Biophysics, University of Minnesota, Minneapolis, MN 55455, USA.
Mehta S; Department of Biochemistry, Molecular Biology and Biophysics, University of Minnesota, Minneapolis, MN 55455, USA.
Nguyen DDA; Department of Biochemistry, Molecular Biology and Biophysics, University of Minnesota, Minneapolis, MN 55455, USA.
Grüning BA; Department of Computer Science, University of Freiburg, Freiburg, Germany.
Johnson JE; Minnesota Supercomputing Institute, University of Minnesota, Minneapolis, MN 55455, USA.
McGowan T; Minnesota Supercomputing Institute, University of Minnesota, Minneapolis, MN 55455, USA.
Griffin TJ; Department of Biochemistry, Molecular Biology and Biophysics, University of Minnesota, Minneapolis, MN 55455, USA.
Jagtap PD; Department of Biochemistry, Molecular Biology and Biophysics, University of Minnesota, Minneapolis, MN 55455, USA.

medRxiv ; 2021 Mar 01.

Article en En | MEDLINE | ID: mdl-33688669

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Tipo de estudio: Diagnostic_studies / Guideline / Prognostic_studies Idioma: En Revista: MedRxiv Año: 2021 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google